Education
About Us
Working with TipRanks
Follow Us
Regencell Bioscience Holdings Ltd. (RGC)
NASDAQ:RGC
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -392.74K | $ -745.59K | $ -769.69K | $ -604.40K | $ -26.46K |
| Operating Income | $ -3.77M | $ -4.74M | $ -6.27M | $ -7.62M | $ -1.38M |
| EBITDA | $ -3.19M | $ -3.62M | $ -5.29M | $ -6.99M | $ -1.35M |
| Net Income | $ -3.58M | $ -4.30M | $ -5.87M | $ -7.42M | $ -1.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.90M | $ 7.96M | $ 11.56M | $ 16.42M | $ 59.41K |
| Total Assets | $ 5.76M | $ 8.44M | $ 12.62M | $ 18.02M | $ 340.13K |
| Total Debt | $ 544.41K | $ 85.74K | $ 463.67K | $ 771.25K | $ 3.68M |
| Net Debt | $ -1.87M | $ -2.88M | $ -1.10M | $ -5.65M | $ 3.62M |
| Total Liabilities | $ 895.31K | $ 219.51K | $ 632.32K | $ 938.03K | $ 4.34M |
| Stockholders' Equity | $ 4.86M | $ 8.22M | $ 12.03M | $ 17.07M | $ -4.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.27M | $ -4.01M | $ -4.99M | $ -6.05M | $ -767.31K |
| Operating Cash Flow | $ -3.11M | $ -4.00M | $ -4.96M | $ -5.27M | $ -767.31K |
| Investing Cash Flow | $ 2.69M | $ 5.24M | $ 58.98K | $ -10.78M | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 102.28K | $ 134.91K | $ 22.41M | $ 439.75K |
Regencell Bioscience Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.